Viewing Study NCT00458458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-12 @ 7:45 PM
Study NCT ID: NCT00458458
Status: UNKNOWN
Last Update Posted: 2012-10-25
First Post: 2007-04-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometriosis View
None Dysmenorrhea View
None Dyspareunia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Endometriosis View
None Dysmenorrhea View
None Pelvic Pain View
None Period Pain View
None Menstrual Cramps View
None Dyspareunia View
None Norethindrone Acetate View
None Lupron Depot View
None Bone Density View
None Lipid Profile View